However, 10% of BPH tissues with negative SRD5A2 expression showed approximately no methylation in the promoter region of SRD5A29, suggesting the existence of other mechanisms regulating SRD5A2 expression in the prostate. The gene discussed is SRD5A2; the disease is benign prostatic hyperplasia.